Sleep apnea, particularly obstructive sleep apnea, poses a significant health challenge that often goes unnoticed. This condition occurs when relaxed throat muscles and soft tissues block...
Alnylam Pharmaceuticals has announced the initiation of a Phase 3 cardiovascular outcomes trial for its hypertension therapy, zilebesiran, later this year. This decision comes despite recent...
